Oppenheimer & CO Inc PROGENICS PHARMACEUTICALS IN Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020
SELL
N/A
-50,000 Closed
0 $0
Q2 2019

Aug 09, 2019
BUY
N/A
50,000 New
50,000 $309,000
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email